246710.Kq
The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies, generating revenue through sales and related services.
Business. The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies, generating revenue through sales and related services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies, generating revenue through sales and related services.
The company's capital structure is characterized by a debt-to-equity ratio of 1.28, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.09, suggesting limited short-term liquidity cushion. The company's cash and equivalents amount to 7,760,524,310 KRW, but this is insufficient to cover its long-term debt of 29,562,311,850 KRW, resulting in a negative net cash position.
Profitability metrics are severely negative, with a return on equity of -1.51 and a return on assets of -0.38, both well below the industry median. The company reported a net loss of 34,944,025,170 KRW and an operating loss of 11,752,134,110 KRW, indicating significant operational inefficiencies and cost overruns.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. No specific geographic breakdown is available in the provided data.
The company's growth trajectory is negative, with no disclosed revenue growth in the most recent fiscal year. The operating cash flow is negative at -7,465,731,900 KRW, and free cash flow is -32,312,012,800 KRW, indicating a lack of cash generation and potential liquidity constraints. The capital expenditure of -2,401,565,320 KRW suggests ongoing investment, but this is not offsetting the negative cash flows.
The company faces significant financial risk, with a liquidity risk score of medium and a key flag indicating negative net cash after subtracting total debt. The dilution risk is assessed as low, with no immediate pressure from share issuance. However, the company's negative net income and operating cash flow suggest potential future dilution if capital raising is required.
Recent events include a reported net loss and negative operating cash flow, as disclosed in the latest financial statements. No recent filings or transcripts are available in the provided data to indicate strategic changes or operational improvements.
- The company is operating at a significant net loss, with a return on equity of -1.51 and a return on assets of -0.38.
- The company's liquidity position is weak, with a current ratio of 1.09 and a negative net cash position.
- The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.28.
- The company's growth trajectory is negative, with no disclosed revenue growth and significant negative cash flows.
- The company's risk profile is high, with a liquidity risk score of medium and a key flag indicating negative net cash after subtracting total debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 246710.KQ Market data — financials · 2026-05-26
- T&R Biofab Co Ltd Market data — analyst estimates · 2026-05-26